Skip to content

Use of guduchi churna with madhu in school going children complaining of vomiting.

An open randomized control clinical trial to study effect of guduchi churna with madhu in the management of chhardi in children. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086228
Enrollment
70
Registered
2025-05-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K90-K95- Other diseases of the digestive system

Interventions

None listed

Sponsors

Dr Girija Ganesh Nagulpelli
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Irrespective of gender and economic condition. 2.vomiting due to indigestion over eating hurried eating and excessive intake of liquid diet. 3.vomiting due to incompatible spicy diet. 4.vomiting due to fried food,dried food,packed and tinned food. 5.Patients with mild dehydration.

Exclusion criteria

Exclusion criteria: 1.Patient of sannipataj and bibhatsadarshanj chhardi. 2.Patients suffering from atisar associated chhardi. 3.Patients suffering from jwara. 4.Patients with disorders like liver cirrhosis,renalfailure,poisoning,hyperthyroidism,congenital anomalies,chronic systemic disorders,head injury and metabolic disorders,etc. 5.Surgical condition like cholecystitis,intestinal obstruction,cancer of stomach,etc.

Design outcomes

Primary

MeasureTime frame
Guduchi churna with madhu is effective in the managementment of chhardi.Timepoint: 5 days

Secondary

MeasureTime frame
Ativisha churna with madhu is effective in the management of chhardi.Timepoint: 5 days.

Countries

India

Contacts

Public ContactDr Nareshkumar Babar

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research center

dr.nareshbabar@gmail.com7507595454

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026